Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand

Diabetes Research and Clinical Practice

Volumn 37, Issue 3, 1997, Pages 193-197

  Rattarasarn, Chatchalit ^a   Diosdado, Manuel Aguilar ^b   Soonthornpun, Supamai ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Glutamic acid decarboxylase antibodies; Insulin dependent diabetes; Non insulin dependent diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; INSULIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN DEFICIENCY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; THAILAND; TREATMENT FAILURE;

ADULT; AGED; ANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; SULFONYLUREA COMPOUNDS; THAILAND; TREATMENT FAILURE;

EID: 0030865141     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00070-3     Document Type: Article

References (16)

1. H. Gleichmann, B. Zorcher, B. Greulich, Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults, Diabetologia 27 (1984) 90-92.
2. A.-C. Thai, G.S. Eisenbarth, Natural history of IDDM, Diabetes Rev. 1 (1993) 1-14.
3. M.J. Clare-Salzler, A.J. Tobin, D.L. Kaufman, Glutamate decarboxylase: An autoantigen in IDDM, Diabetes Care 15 (1992) 132-135.
4. T. Tuomi, L.C. Groop, P.Z. Zimmet, M.J. Rowley, W. Knowles, I.R. Mackay, Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease, Diabetes 42 (1993) 359-362.
5. A. Tsuruoka, I. Matsuba, T. Toyota, G. Isshiki, S. Nagataki, Y. Ikeda, Antibodies to GAD in Japanese diabetic patients: A multicenter study, Diabetes Res. Clin. Pract. 28 (1995) 191-199.
6. H.J. Gjessing, C-peptide used in the estimation of islet beta-cell function in diabetes, Danish Med. Bull. 39 (1992) 438-452.
7. O. Hother-Nielsen, O. Faber, N.S. Sørensen, H. Beck-Nielsen, Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables, Diabetes Care 11 (1988) 531-537.
8. R.S. Schmidli, P.G. Colman, E. Bonifacio, Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: The second international GAD Ab workshop, Diabetes 44 (1995) 636-640.
9. 65) shows that 64K autoantibody positivity at onset predicts diabetes type, J Clin. Invest. 91 (1993) 368-374.
10. T. Kobayashi, K. Tamemoto, K. Nakanishi, Immunogenetic and clinical characterization of slowly progressive IDDM, Diabetes Care 16 (1993) 780-788.
11. L.C. Groop, G.F. Bottazzo, D. Doniach, Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis, Diabetes 35 (1986) 237-241.
12. A. Kasuga, T. Maruyama, Y. Ozawa, Antibodies to the M (r) 65 000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese, J. Autoimmun. 9 (1996) 105-111.
13. J. Tuomilehto, P. Zimmet, I.R. Mackay, Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease, Lancet 343 (1994) 1383-1385.
14. T. Lindstrom, P. Erisksson, A.G. Olsson, H.J. Arnqvist, Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure, Diabetes Care 17 (1994) 719-721.
15. L. Groop, C. Schalin, A. Franssila-Kallunki, E. Widen, A. Ekstrand, J. Eriksson, Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy, Am. J. Med. 87 (1989) 183-190.
16. L.C. Groop, R. Pelkonen, G. Koskimies, G. Bottazzo, D. Doniach, Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes, Diabetes Care 9 (1986) 129-133.